Overview
Nail-patella syndrome (NPS), also known as hereditary osteo-onychodysplasia (HOOD syndrome), Fong disease, or Turner-Kieser syndrome, is a rare genetic disorder caused by mutations in the LMX1B gene located on chromosome 9q34. This gene encodes a transcription factor critical for the development of the limbs, kidneys, and eyes. NPS is characterized by a classic tetrad of abnormalities affecting the nails, knees, elbows, and pelvis. Nail changes are the most consistent feature and typically include absent, hypoplastic, or dystrophic fingernails, most severely affecting the thumbnails and index fingernails. The patellae (kneecaps) are often small, irregularly shaped, or completely absent, leading to knee instability and recurrent dislocations. Skeletal manifestations also include iliac horns — bony projections from the posterior iliac bones that are virtually pathognomonic for the condition — as well as limited elbow extension, cubitus valgus, and radial head subluxation or dislocation. Beyond the musculoskeletal system, NPS can affect the kidneys, with approximately 30–50% of patients developing nephropathy characterized by proteinuria and, in a smaller percentage (roughly 5–10%), progression to end-stage renal disease. Ocular involvement includes open-angle glaucoma and ocular hypertension, which may develop at a younger age than in the general population. Some patients also experience peripheral neuropathy and vasomotor disturbances. There is currently no cure for nail-patella syndrome, and management is symptomatic and multidisciplinary. Orthopedic interventions may be needed for joint instability or skeletal deformities. Regular monitoring of kidney function (urinalysis and blood pressure) is essential, and nephropathy is managed with ACE inhibitors or angiotensin receptor blockers when proteinuria is detected. Ophthalmologic screening for glaucoma is recommended. Genetic counseling is important given the autosomal dominant inheritance pattern, with each affected individual having a 50% chance of passing the condition to their offspring. The clinical expression is highly variable, even within the same family.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Nail-patella syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Nail-patella syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Nail-patella syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Nail-patella syndrome.
Community
No community posts yet. Be the first to share your experience with Nail-patella syndrome.
Start the conversation →Latest news about Nail-patella syndrome
No recent news articles for Nail-patella syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Nail-patella syndrome
What is Nail-patella syndrome?
Nail-patella syndrome (NPS), also known as hereditary osteo-onychodysplasia (HOOD syndrome), Fong disease, or Turner-Kieser syndrome, is a rare genetic disorder caused by mutations in the LMX1B gene located on chromosome 9q34. This gene encodes a transcription factor critical for the development of the limbs, kidneys, and eyes. NPS is characterized by a classic tetrad of abnormalities affecting the nails, knees, elbows, and pelvis. Nail changes are the most consistent feature and typically include absent, hypoplastic, or dystrophic fingernails, most severely affecting the thumbnails and index
How is Nail-patella syndrome inherited?
Nail-patella syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Nail-patella syndrome typically begin?
Typical onset of Nail-patella syndrome is neonatal. Age of onset can vary across affected individuals.